1.Expression and clinical significance of costimulatory molecule B7-H3 mRNA and B7-H3 protein in gastric carcinoma.
Jie-min ZHAO ; Chang-ping WU ; Rong-chao WANG ; Jun XU ; Jiang ZHU ; Jiang WEI ; Guang-hua LUO ; Liang-rong SHI ; Min TAN ; Yan TAN
Chinese Journal of Gastrointestinal Surgery 2007;10(5):458-462
OBJECTIVETo study the expression of B7-H3 mRNA and B7-H3 protein in gastric carcinoma and their clinical significance.
METHODSThe expression of B7-H3 mRNA and B7-H3 protein in gastric carcinoma and the nearby normal tissue of 38 patients was detected by real-time RT-PCR and immunohistochemical assay respectively.
RESULTSB7-H3 mRNA was expressed both in gastric carcinoma and nearby normal tissue, but the expression level in gastric carcinoma was much lower than that in nearby normal tissue. There were no significant differences of B7-H3 mRNA expression among gender, age, histological type, tumor size, lymph node metastasis and invasive depth (all P >0.05). The positive rate of B7-H3 protein expressed in gastric carcinoma was 39.5%. There were no significant differences of B7-H3 protein expression among gender, age, histological type, tumor size, lymph node metastasis and invasive depth (all P >0.05), but there were significant differences among groups of clinical stage (P=0.022) and pathological grade (P=0.039). Kaplan-Meier analysis revealed that disease-free survival or overall survival of the patients with positive B7-H3 expression were significantly longer than those with negative B7-H3 expression (P=0.009 and P=0.010 respectively).
CONCLUSIONDetection of B7-H3 expression in gastric carcinoma will be beneficial to the judgment of the prognosis of gastric carcinoma and the choice of individualized treatment.
Antigens, CD ; genetics ; metabolism ; B7 Antigens ; Biomarkers, Tumor ; genetics ; metabolism ; Cytotoxicity, Immunologic ; Female ; Humans ; Middle Aged ; Neoplasm Staging ; RNA, Messenger ; genetics ; Receptors, Immunologic ; genetics ; metabolism ; Stomach Neoplasms ; genetics ; metabolism ; pathology
2.Complement genetics, deficiencies, and disease associations.
Protein & Cell 2012;3(7):487-496
The complement system is a key component of innate immunity. More than 45 genes encoding the proteins of complement components or their isotypes and subunits, receptors, and regulators have been discovered. These genes are distributed throughout different chromosomes, with 19 genes comprising three significant complement gene clusters in the human genome. Genetic deficiency of any early component of the classical pathway (C1q, C1r/s, C2, C4, and C3) is associated with autoimmune diseases due to the failure of clearance of immune complexes (IC) and apoptotic materials, and the impairment of normal humoral response. Deficiencies of mannan-binding lectin (MBL) and the early components of the alternative (factor D, properdin) and terminal pathways (from C3 onward components: C5, C6, C7, C8, C9) increase susceptibility to infections and their recurrence. While the association of MBL deficiency with a number of autoimmune and infectious disorders has been well established, the effects of the deficiency of other lectin pathway components (ficolins, MASPs) have been less extensively investigated due to our incomplete knowledge of the genetic background of such deficiencies and the functional activity of those components. For complement regulators and receptors, the consequences of their genetic deficiency vary depending on their specific involvement in the regulatory or signalling steps within the complement cascade and beyond. This article reviews current knowledge and concepts about the genetic load of complement component deficiencies and their association with diseases. An integrative presentation of genetic data with the latest updates provides a background to further investigations of the disease association investigations of the complement system from the perspective of systems biology and systems genetics.
Animals
;
Complement Activation
;
genetics
;
Complement System Proteins
;
deficiency
;
genetics
;
HLA Antigens
;
genetics
;
Humans
;
Immunity, Innate
;
genetics
;
Immunologic Deficiency Syndromes
;
genetics
;
Lectins
;
metabolism
;
Multigene Family
;
Receptors, Complement
;
genetics
3.Expression of leukocyte immunoglobulin-like receptor A3 in CD14 monocytes of patients with rheumatoid arthritis.
Meiju ZHOU ; Jiawei WANG ; Wenjia SUN ; Xinyu WU ; Jing XUE ; Huaxiang WU ; Yan DU
Journal of Zhejiang University. Medical sciences 2018;47(4):395-399
OBJECTIVE:
To investigate the expression of leukocyte immunoglobulin-like receptor A3 (LILRA3) in CD14 monocytes of patients with rheumatoid arthritis (RA).
METHODS:
Fifty three RA patients admitted in the Second Affiliated Hospital of Zhejiang University School of Medicine from February 2017 to August 2017, and 21 healthy subjects were enrolled in the study. The expression of LILRA3 in CD14 monocyte subset was determined by flow cytometry, and its correlations with clinical features, laboratory examination results, antibodies and disease activity were analyzed.
RESULTS:
LILRA3 percentage in the CD14 monocyte subset of RA patients was higher than that in the healthy controls (<0.01). The percentage of LILRA3 was positively correlated with number of tenderness joints, number of swollen joints and erythrocyte sedimentation rate (=0.280, 0.371, 0.341, <0.05 or <0.01), but was not correlated with the age, course of disease, Sharp score, C reactive protein, blood routine index and immunoglobulin (all >0.05). In addition, the percentages of LILRA3 in the monocytes of rheumatoid factor (RF)-positive or anti-cyclic citrullinated peptide (CCP) antibody-positive patients were significantly higher than those of the RF-or anti-CCP antibody-negative patients (all < 0.05); and the percentage of LILRA3 in patients with DAS28>5.1 was higher than that in patients with DAS28 ≤ 5.1 (<0.05).
CONCLUSIONS
The expression of LILRA3 is up-regulated in CD14 monocyte subset isolated from RA patients, and it is correlated with disease activity.
Arthritis, Rheumatoid
;
blood
;
physiopathology
;
Autoantibodies
;
blood
;
Biomarkers
;
blood
;
Flow Cytometry
;
Humans
;
Monocytes
;
metabolism
;
Receptors, Immunologic
;
genetics
;
Up-Regulation
4.Expression of endotoxin receptors on hepatic stellate cells during their activation.
Jing HUA ; De-kai QIU ; Ji-qiang LI ; En-ling LI
Chinese Journal of Hepatology 2006;14(11):817-820
OBJECTIVETo investigate the role of endotoxin receptor expression in the activation of hepatic stellate cells (HSCs).
METHODSHSCs were isolated from normal rats and the expression of endotoxin receptors on quiet HSCs and in vitro activated HSCs was determined using RT-PCR and immunocytochemical staining methods. A rat model of liver fibrosis and cirrhosis was established. The expressions of CD14 and alpha-SMA in liver tissues were detected by immunohistochemical staining.
RESULTSFreshly isolated HSCs had a low level of CD14 mRNA expression and no expression of TLR4 mRNA was detected. The in vitro activated HSCs had increased expressions of CD14 mRNA and TLR4 mRNA and LPS up-regulated the expression of endotoxin receptors. Immunocytochemical staining showed cytoplasmic and nucleolus staining for CD14 in the cultured HSCs. LPS played a further role on CD14 protein expression. In the development of liver fibrosis, the number of CD14-positive cells in the livers was increased and these cells were distributed along the sinusoids. In the later stage of liver fibrosis, the CD14-positive cells were gathered in the fibrotic septae, which also contained alpha-SMA positive cells.
CONCLUSIONThe activated HSCs expressed endotoxin receptors. The endotoxin receptors may be involved in the role in which HSCs played in the inflammatory process and liver fibrosis development.
Actins ; metabolism ; Animals ; Cells, Cultured ; Hepatic Stellate Cells ; metabolism ; Lipopolysaccharide Receptors ; metabolism ; Liver Cirrhosis ; metabolism ; pathology ; RNA, Messenger ; genetics ; Rats ; Rats, Wistar ; Receptors, Immunologic ; genetics ; metabolism ; Reverse Transcriptase Polymerase Chain Reaction
5.Progress on the study of HLA-Cw--review.
Hong-Jing MA ; Lu-Lu XIAO ; Kun-Yuan GUO
Journal of Experimental Hematology 2004;12(5):699-703
HLA-Cw belongs to classic HLA-I gene, HLA-Cw molecules have high polymorphism like HLA-A and B molecules. They distribute extensively on the surfaces of karyote, not only presenting endogenetic antigen to CD8+ T cells to induce specific killing effect, but also participating in immunologic reaction as the ligands of killer cell immunoglobulin-like receptor (KIR). Thus it has been valued for their relations to diseases and the functions in transplantation immunity, anti virus and anti-tumor immunity.
Autoimmune Diseases
;
immunology
;
Graft vs Host Disease
;
etiology
;
HLA-C Antigens
;
genetics
;
physiology
;
Humans
;
Neoplasms
;
immunology
;
Receptors, Immunologic
;
metabolism
;
Receptors, KIR
;
Virus Diseases
;
immunology
6.Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer's disease.
Bo Ryoung CHOI ; Woo Hyun CHO ; Jiyoung KIM ; Hyong Joo LEE ; Chihye CHUNG ; Won Kyung JEON ; Jung Soo HAN
Experimental & Molecular Medicine 2014;46(2):e75-
The receptor for advanced glycation end products (RAGE) has been reported to have a pivotal role in the pathogenesis of Alzheimer's disease (AD). This study investigated RAGE levels in the hippocampus and cortex of a triple transgenic mouse model of AD (3xTg-AD) using western blotting and immunohistochemical double-labeling to assess cellular localization. Analysis of western blots showed that there were no differences in the hippocampal and cortical RAGE levels in 10-month-old adult 3xTg-AD mice, but significant increases in RAGE expression were found in the 22- to 24-month-old aged 3xTg-AD mice compared with those of age-matched controls. RAGE-positive immunoreactivity was observed primarily in neurons of aged 3xTg-AD mice with very little labeling in non-neuronal cells, with the notable exception of RAGE presence in astrocytes in the hippocampal area CA1. In addition, RAGE signals were co-localized with the intracellular amyloid precursor protein (APP)/amyloid beta (Abeta) but not with the extracellular APP/Abeta. In aged 3xTg-AD mice, expression of human tau was observed in the hippocampal area CA1 and co-localized with RAGE signals. The increased presence of RAGE in the 3xTg-AD animal model showing critical aspects of AD neuropathology indicates that RAGE may contribute to cellular dysfunction in the AD brain.
Advanced Glycosylation End Product-Specific Receptor
;
Alzheimer Disease/genetics/*metabolism
;
Amyloid beta-Peptides/metabolism
;
Animals
;
Astrocytes/*metabolism
;
CA1 Region, Hippocampal/growth & development/metabolism/pathology
;
Humans
;
Mice
;
Mice, Transgenic
;
Neurons/*metabolism
;
Receptors, Immunologic/genetics/*metabolism
;
tau Proteins/genetics/metabolism
7.Role of RAGE in lipopolysaccharide-induced cytoskeletal changes in mouse pulmonary microvascular endothelial cells.
Xiao-Yan ZHOU ; Wei-Jin ZHANG ; Qiao-Bing HUANG ; Xiao-Hua GUO
Journal of Southern Medical University 2015;35(1):6-11
OBJECTIVETo investigate lipopolysaccharide (LPS)-induced changes of cytoskeletal filamentous actin in primary isolated pulmonary microvascular endothelial cells (PMVECs) from wild-type and RAGE knock-out mouse.
METHODSThe lungs of wild-type and RAGE knock-out mice were digested with collagenase type I to obtain endothelial cells purified by anti-CD31-coupled magnetic beads. The PMVEC identified by factor VIII labeling were stimulated with LPS at different concentrations and the changes of filamentous actin were observed by confocal microscopy.
RESULTSThe cultured primary cells showed typical endothelial cell phenotype as examined with factor VIII labeling. LPS stimulation caused rearrangement of the cytoskeletal filament F-actin in wild-type mouse PMVECs with stress fiber formation, but such changes were not obvious in RAGE knock-out mouse PMVECs.
CONCLUSIONMouse PMVECs of a high purity can be obtained by immune magnetic beads. RAGE is involved in LPS-induced destruction of mouse PMVEC cytoskeletons.
Actins ; metabolism ; Animals ; Cells, Cultured ; Cytoskeleton ; metabolism ; Endothelial Cells ; cytology ; Lipopolysaccharides ; Lung ; cytology ; Mice ; Mice, Knockout ; Microvessels ; cytology ; Phenotype ; Receptor for Advanced Glycation End Products ; Receptors, Immunologic ; genetics ; metabolism
9.Association between Slit/Robo signal pathway and the genesis, progression, invasion and metastasis of malignant tumors.
Li ZHAO ; Feng GU ; Yong-jie MA
Chinese Journal of Oncology 2012;34(6):405-408
Apoptosis
;
Cell Proliferation
;
DNA Methylation
;
Humans
;
Intercellular Signaling Peptides and Proteins
;
genetics
;
metabolism
;
Membrane Proteins
;
genetics
;
metabolism
;
Neoplasm Invasiveness
;
Neoplasm Metastasis
;
Neoplasms
;
metabolism
;
pathology
;
Neovascularization, Pathologic
;
Nerve Tissue Proteins
;
genetics
;
metabolism
;
Promoter Regions, Genetic
;
Receptors, Immunologic
;
genetics
;
metabolism
;
Signal Transduction
10.High affinity soluble ILT2 receptor: a potent inhibitor of CD8(+) T cell activation.
Ruth K MOYSEY ; Yi LI ; Samantha J PASTON ; Emma E BASTON ; Malkit S SAMI ; Brian J CAMERON ; Jessie GAVARRET ; Penio TODOROV ; Annelise VUIDEPOT ; Steven M DUNN ; Nicholas J PUMPHREY ; Katherine J ADAMS ; Fang YUAN ; Rebecca E DENNIS ; Deborah H SUTTON ; Andy D JOHNSON ; Joanna E BREWER ; Rebecca ASHFIELD ; Nikolai M LISSIN ; Bent K JAKOBSEN
Protein & Cell 2010;1(12):1118-1127
Using directed mutagenesis and phage display on a soluble fragment of the human immunoglobulin super-family receptor ILT2 (synonyms: LIR1, MIR7, CD85j), we have selected a range of mutants with binding affinities enhanced by up to 168,000-fold towards the conserved region of major histocompatibility complex (MHC) class I molecules. Produced in a dimeric form, either by chemical cross-linking with bivalent polyethylene glycol (PEG) derivatives or as a genetic fusion with human IgG Fc-fragment, the mutants exhibited a further increase in ligand-binding strength due to the avidity effect, with resident half-times (t(1/2)) on the surface of MHC I-positive cells of many hours. The novel compounds antagonized the interaction of CD8 co-receptor with MHC I in vitro without affecting the peptide-specific binding of T-cell receptors (TCRs). In both cytokine-release assays and cell-killing experiments the engineered receptors inhibited the activation of CD8(+) cytotoxic T lymphocytes (CTLs) in the presence of their target cells, with subnanomolar potency and in a dose-dependent manner. As a selective inhibitor of CD8(+) CTL responses, the engineered high affinity ILT2 receptor presents a new tool for studying the activation mechanism of different subsets of CTLs and could have potential for the development of novel autoimmunity therapies.
Amino Acid Sequence
;
Antigens, CD
;
chemistry
;
genetics
;
pharmacology
;
Autoimmunity
;
Biological Assay
;
Cell Line
;
Cytotoxicity, Immunologic
;
genetics
;
immunology
;
Dose-Response Relationship, Immunologic
;
Humans
;
Immunoglobulins
;
immunology
;
metabolism
;
Immunologic Factors
;
chemistry
;
genetics
;
pharmacology
;
Kinetics
;
Leukocyte Immunoglobulin-like Receptor B1
;
Lymphocyte Activation
;
genetics
;
immunology
;
Major Histocompatibility Complex
;
genetics
;
immunology
;
Molecular Sequence Data
;
Molecular Targeted Therapy
;
Mutagenesis, Site-Directed
;
Peptide Library
;
Polyethylene Glycols
;
Protein Binding
;
genetics
;
immunology
;
Receptors, Immunologic
;
chemistry
;
genetics
;
Recombinant Fusion Proteins
;
genetics
;
metabolism
;
T-Lymphocytes, Cytotoxic
;
immunology
;
metabolism